Calendar ISIS Pharmaceuticals, Inc. Nasdaq
Stocks
US4643301090
Biotechnology & Medical Research
Upcoming events on ISIS Pharmaceuticals, Inc.
No events available
Past events on ISIS Pharmaceuticals, Inc.
| 2026-09-04 | Information meeting | 10:00 |
| 2026-07-29 | Earnings release - Q2 2026 | |
| 2026-07-29 | Earnings presentation | 08:30 |
| 2026-06-24 | Information meeting | 15:30 |
| 2026-06-04 | Présentation aux Actionnaires / Analystes | 17:00 |
| 2026-06-04 | Annual General Meeting | 17:00 |
| 2026-06-04 | Information meeting | 17:30 |
| 2026-04-29 | Earnings presentation | 08:30 |
| 2026-02-25 | Earnings presentation | 08:30 |
| 2025-11-08 | Information meeting | 15:00 |
| 2025-10-29 | Earnings presentation | 11:30 |
| 2025-10-07 | Présentation aux Actionnaires / Analystes | 08:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 788 634 24.31% | 705 620 13.69% | 944 897 5.18% | 913 | 1 402 | 1 985 |
|
EBITDA Million USD | Released Forecast Spread | -343 -399 14.09% | -465 -506 8.01% | -372 -315 -18.17% | -569 | -295 | 89,9 |
|
EBIT Million USD | Released Forecast Spread | -353 -464 23.98% | -475 -516 7.9% | -382 -359 -6.36% | -590 | -311 | 85,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -334 -455 26.55% | -460 -528 12.94% | -380 -355 -7.11% | -585 | -319 | 42,2 |
|
Net income Million USD | Released Forecast Spread | -366 -473 22.64% | -454 -525 13.52% | -381 -356 -6.96% | -583 | -311 | 38,6 |
|
EPS USD | Released Forecast Spread | -2,56 -3,33 23.13% | -3,04 -3,51 13.4% | -2,38 -2,26 -5.53% | -3,64 | -1,84 | 0,19 |
| Announcement Date | 21/02/24 | 19/02/25 | 25/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 227 141 61.05% | 132 123 7.75% | 452 299 51.18% | 157 131 20.3% | 203 156 30.02% | 246 196 25.5% | 268 190 40.99% | 184 | 231 | 260 | 282 | 366 | 428 |
|
EBITDA Million USD | Released Forecast Spread | -108 -156 30.98% | 142 55,0 158.33% | -158 -194 18.43% | -211 -202 -4.54% | -98,9 -188 47.31% | -214 | -159 | -139 | -155 | ||||
|
EBIT Million USD | Released Forecast Spread | -110 -172 36.02% | -146 -178 17.75% | 140 -14,9 1042.34% | -160 -200 19.82% | -215 -213 -1.06% | -118 -141 16.09% | -102 -180 43.39% | -199 | -172 | -143 | -133 | -49,9 | -12,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -107 -177 39.39% | -147 -180 18.11% | 124 -15,4 903.61% | -129 -204 36.79% | -228 -211 -8.11% | -93,0 -141 33.89% | -114 -184 38.03% | -193 | -177 | -134 | -126 | -50,6 | -13,9 |
|
Net income Million USD | Released Forecast Spread | -104 -177 41.3% | -147 -181 18.56% | 124 -11,4 1184.33% | -129 -201 35.87% | -229 -209 -9.7% | -93,0 -146 36.32% | -115 -183 37.01% | -193 | -175 | -127 | -122 | -52,8 | -10,2 |
|
EPS USD | Released Forecast Spread | -0,66 -1,13 41.57% | -0,93 -1,13 17.81% | 0,70 -0,09 870.93% | -0,80 -1,23 35.11% | -1,41 -1,32 -6.84% | -0,56 -0,91 38.25% | -0,69 -1,07 35.79% | -1,21 | -1,12 | -0,80 | -0,75 | -0,28 | -0,34 |
| Announcement Date | 19/02/25 | 30/04/25 | 30/07/25 | 29/10/25 | 25/02/26 | 29/04/26 | 29/07/26 | - | - | - | - | - | - |
| 2026-09-07 |  | Earnings presentation | 21:00 |
| 2026-09-07 | | Annual General Meeting | |
| 2026-09-08 | | Information meeting | 07:00 |
| 2026-09-08 | | Extraordinary General Meeting | 11:00 |
| 2026-09-08 | | Information meeting | 08:00 |
| 2026-09-08 | | Présentation aux Actionnaires / Analystes | 17:00 |
| 2026-09-09 | | Earnings presentation | 04:30 |
| 2026-09-09 | | Extraordinary General Meeting | 22:00 |
| 2026-09-09 | | Information meeting | 10:00 |
| 2026-09-10 | | Extraordinary General Meeting | 02:30 |
Past sector events for ISIS Pharmaceuticals, Inc.
| Today | | Significant Split/Dividend | 00:00 |
| 2026-09-03 | | Information meeting | 20:01 |
| 2026-09-02 | | Annual General Meeting | 13:00 |
| 2026-09-02 | | Présentation aux Actionnaires / Analystes | 13:00 |
| 2026-09-02 | | Présentation aux Actionnaires / Analystes | |
| 2026-09-01 | | Information meeting | 13:00 |
| 2026-08-31 | | Information meeting | 08:30 |
| 2026-08-30 | | Board of Directors Meeting | |
| 2026-08-30 | | Earnings release - Q2 2026 | |
| 2026-08-30 | | Board of Directors Meeting |
